Table 1: Main characteristics of the cohort.

Past medical history

Number

%

COPD

28

39

Hypertension

21

30

Diabetus mellitus

9

13

Pulmonary post Tuberculous sequellae

9

13

Gastro-duodenal ulcer

9

13

Histological subtype

Number

%

Squamous cell carcinoma

18

25

Adenocarcinoma

41

58

Others

12

17

Chemotherapy protocol

Number

%

Cisplatin - Vinorelbine

28

39

Cisplatin - Gemcitabine

23

32

Carboplatin - Paclitaxel

20

29

Stage

Number

%

T

1c

1

1

2b

9

13

3

16

23

4

45

63

N

0

11

15

1

9

13

2

34

48

3

17

24

M

1a

19

27

1b

24

34

1c

28

39

Adverse events (AE)

Number

%

Neutropenia

16

22

Vomiting

9

12

Anemia

5

7